CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Regeneron Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 7, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Enhanced Production Of ImmunoglobulinsTRIANNIJan 24, 2025
Dosing Regimen For Anti-Bcma AgentsAMGENAug 2, 2024
Dosing Regimen For Anti-Bcma AgentsAMGENAug 2, 2024
Treatment Of Lag-3 Positive TumorsBRISTOL MYERS SQUIBBJun 13, 2024
Aav-Mediated Gene Therapy Restoring The Otoferlin GeneCENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRSApr 16, 2024
Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (Pcsk9)AMGENFeb 19, 2024
Human Antibodies That Bind Lymphocyte Activation Gene-3 (Lag-3) And Uses ThereofE R SQUIBB & SONSMay 23, 2023
Long Germline Dh Genes And Long Hcdr3 AntibodiesTRIANNIOct 25, 2022
Adam6 Knockin MiceTRIANNIOct 25, 2022
Animal Models And Therapeutic MoleculesKYMABFeb 25, 2022

Explore Regeneron Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Sep 25, 2024Methods For Reducing Lipoprotein(A) Levels By Administering An Inhibitor Of Proprotein Convertase Subtilisin Kexin-9 (Pcsk9)1
Jul 31, 2024Methods For Preventing Or Treating Allergy By Administering An Il-4R Antagonist4
Apr 24, 2024Methods For Treating Atopic Dermatitis By Administering An Il-4R Antagonist7
Mar 13, 2024Methods And Compositions For The Targeted Modification Of A Genome1
Feb 14, 2024Methods For Treating Skin Infection By Administering An Il-4R Antagonist5
Feb 7, 2024Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R Inhibitor7
Jan 10, 2024Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist6
Nov 15, 2023Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist6
Nov 1, 2023Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist7
Aug 9, 2023Transgenic Mice Expressing Chimeric Major Histocompatibility Complex (Mhc) Class Ii Molecules1

Top competitors of Regeneron Pharmaceuticals

List of top competitors of Regeneron Pharmaceuticals based on patent oppositions.